Drug intelligence / Profile preview

EV201

Development stage
Preclinical
Lead developer
Pfizer
Modality
Vaccines & Immunotherapeutics, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
01

Overview

EV201 is a preclinical therapeutic vaccine candidate developed by EV Therapeutics for the treatment of pancreatic ductal adenocarcinoma (PDAC). The therapy utilizes modified tumor-derived extracellular vesicles (mTEV) as a delivery platform for tumor-derived neoantigens. By leveraging the natural biocompatibility and signaling properties of extracellular vesicles, EV201 is designed to present these neoantigens to the immune system, thereby inducing a targeted anti-tumor T-cell response. It is being evaluated both as a standalone monotherapy and in combination with immune checkpoint inhibitors to enhance therapeutic efficacy in the immunosuppressive microenvironment of pancreatic cancer.

Other names
mTEV therapeutic vaccinemodified Tumor-derived Extracellular Vesicles
02

Targets

PVRL4 (Nectin cell adhesion molecule 4)

Beyond the preview

Go deeper on EV201.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on EV201.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call